Neoadjuvant

PS 0-1

PS 2+

Pancreatic Cancer

Updated: 2017-09-15

Regimens are being updated.

COMMENTS from Pathway Team

CH PANC 2: Gem + XRT
CH PANC 3: 5FU + XRT
CH PANC 4: Cape + XRT
CH PANC 8: Gem + nab-Paclitaxel

CH PANC 1: Folfirinox
CH PANC 2: Gem + XRT
CH PANC 8: Gem + nab-Paclitaxel

Adjuvant

Regimens are being updated.

COMMENTS from Pathway Team

CH PANC 5: Gem-5FU/XRT-Gem
CH PANC 6: Gemcitabine
CH PANC 7: 5FU/Leucovorin
CH PANC 11: Gem-Cape/XRT-Gem

Pancreatic Cancer

Updated: 2017-09-15

Locally Advanced

PS 0-1

PS 2+

Regimens are being updated.

COMMENTS from Pathway Team

CH PANC 1: Folfirinox

CH PANC 2: Gem + XRT
CH PANC 3: 5FU + XRT
CH PANC 4: Cape + XRT

CH PANC 6: Gemcitabine
CH PANC 8: Gem + nab-Paclitaxel

CH PANC 6: Gemcitabine
CH PANC 8: Gem + nab-Paclitaxel

CH PANC 2: Gem + XRT
CH PANC 3: 5FU + XRT
CH PANC 4: Cape + XRT
CH PANC 6: Gemcitabine
CH PANC 8: Gem + nab-Paclitaxel

CH PANC 1: Folfirinox
CH PANC 6: Gemcitabine
CH PANC 8: Gem + nab-Paclitaxel
CH PANC 9: FOLFOX
CH PANC 10: CapeOx

CH PANC 1: Folfirinox
CH PANC 2: Gem + XRT
CH PANC 3: 5FU + XRT
CH PANC 4: Cape + XRT
CH PANC 9: FOLFOX
CH PANC 10: CapeOx

Pancreatic Cancer

Updated: 2017-09-15

Metastatic or Recurrent

PS 0-1

Mismatch Repair Testing

PS 2+

Regimens are being updated.

COMMENTS from Pathway Team

CH PANC 6: Gemcitabine
CH PANC 8: Gem + nab-Paclitaxel

CH PANC 12: Pembrolizumab

CH PANC 1: Folfirinox
CH PANC 6: Gemcitabine
CH PANC 8: Gem + nab-Paclitaxel

Pancreatic Cancer

Updated: 2017-09-15

Positive

NEGATIVE
(or) No Tissue